Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Antibiotic resistance prediction for Mycobacterium tuberculosis from genome sequence data with Mykrobe.

Hunt M, Bradley P, Lapierre SG, Heys S, Thomsit M, Hall MB, Malone KM, Wintringer P, Walker TM, Cirillo DM, Comas I, Farhat MR, Fowler P, Gardy J, Ismail N, Kohl TA, Mathys V, Merker M, Niemann S, Omar SV, Sintchenko V, Smith G, van Soolingen D, Supply P, Tahseen S, Wilcox M, Arandjelovic I, Peto TEA, Crook DW, Iqbal Z.

Wellcome Open Res. 2019 Dec 2;4:191. doi: 10.12688/wellcomeopenres.15603.1. eCollection 2019.

2.

Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data.

Dean AS, Zignol M, Cabibbe AM, Falzon D, Glaziou P, Cirillo DM, Köser CU, Gonzalez-Angulo LY, Tosas-Auget O, Ismail N, Tahseen S, Ama MCG, Skrahina A, Alikhanova N, Kamal SMM, Floyd K.

PLoS Med. 2020 Jan 21;17(1):e1003008. doi: 10.1371/journal.pmed.1003008. eCollection 2020 Jan.

3.

World Health Organization 2018 treatment guidelines for rifampicin-resistant tuberculosis: uncertainty, potential risks and the way forward.

Van Deun A, Decroo T, Tahseen S, Trébucq A, Schwoebel V, Ortuno-Gutierrez N, de Jong BC, Rieder HL, Piubello A, Chiang CY.

Int J Antimicrob Agents. 2020 Jan;55(1):105822. doi: 10.1016/j.ijantimicag.2019.10.003. Epub 2019 Oct 15.

PMID:
31626907
4.

In reply: A human rights-based approach to tuberculosis diagnosis.

Van Deun A, Tahseen S, Affolabi D, Hossain MA, Joloba ML, Angra PK, Ridderhof JC, de Jong BC, Rieder HL.

Int J Tuberc Lung Dis. 2019 Aug 1;23(8):959-960. doi: 10.5588/ijtld.18.0133. No abstract available.

PMID:
31533887
5.

Primary drug resistance in extra-pulmonary tuberculosis: a hospital-based prospective study from Pakistan.

Tahseen S, Ambreen A, Masood F, Qadir M, Hussain A, Jamil M, Safdar N, Sviland L, Mustafa T.

Int J Tuberc Lung Dis. 2019 Aug 1;23(8):900-906. doi: 10.5588/ijtld.18.0531.

PMID:
31533879
6.

Acquisition of Cross-Resistance to Bedaquiline and Clofazimine following Treatment for Tuberculosis in Pakistan.

Ghodousi A, Rizvi AH, Baloch AQ, Ghafoor A, Khanzada FM, Qadir M, Borroni E, Trovato A, Tahseen S, Cirillo DM.

Antimicrob Agents Chemother. 2019 Aug 23;63(9). pii: e00915-19. doi: 10.1128/AAC.00915-19. Print 2019 Sep.

7.

Sputum smear microscopy in the Xpert® MTB/RIF era.

Van Deun A, Tahseen S, Affolabi D, Hossain MA, Joloba ML, Angra PK, Ridderhof JC, de Jong BC, Rieder HL.

Int J Tuberc Lung Dis. 2019 Jan 1;23(1):12-18. doi: 10.5588/ijtld.18.0553. Epub 2018 Dec 19.

PMID:
30567624
8.

Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.

CRyPTIC Consortium and the 100,000 Genomes Project, Allix-Béguec C, Arandjelovic I, Bi L, Beckert P, Bonnet M, Bradley P, Cabibbe AM, Cancino-Muñoz I, Caulfield MJ, Chaiprasert A, Cirillo DM, Clifton DA, Comas I, Crook DW, De Filippo MR, de Neeling H, Diel R, Drobniewski FA, Faksri K, Farhat MR, Fleming J, Fowler P, Fowler TA, Gao Q, Gardy J, Gascoyne-Binzi D, Gibertoni-Cruz AL, Gil-Brusola A, Golubchik T, Gonzalo X, Grandjean L, He G, Guthrie JL, Hoosdally S, Hunt M, Iqbal Z, Ismail N, Johnston J, Khanzada FM, Khor CC, Kohl TA, Kong C, Lipworth S, Liu Q, Maphalala G, Martinez E, Mathys V, Merker M, Miotto P, Mistry N, Moore DAJ, Murray M, Niemann S, Omar SV, Ong RT, Peto TEA, Posey JE, Prammananan T, Pym A, Rodrigues C, Rodrigues M, Rodwell T, Rossolini GM, Sánchez Padilla E, Schito M, Shen X, Shendure J, Sintchenko V, Sloutsky A, Smith EG, Snyder M, Soetaert K, Starks AM, Supply P, Suriyapol P, Tahseen S, Tang P, Teo YY, Thuong TNT, Thwaites G, Tortoli E, van Soolingen D, Walker AS, Walker TM, Wilcox M, Wilson DJ, Wyllie D, Yang Y, Zhang H, Zhao Y, Zhu B.

N Engl J Med. 2018 Oct 11;379(15):1403-1415. doi: 10.1056/NEJMoa1800474. Epub 2018 Sep 26.

9.

Reverse line probe assay for cheap detection of Single Nucleotide Polymorphisms in Mycobacterium tuberculosis.

Yasmin M, Refregier G, Siddiqui RT, Iqbal R, Abbasi SA, Tahseen S.

Tuberculosis (Edinb). 2018 May;110:52-55. doi: 10.1016/j.tube.2018.03.007. Epub 2018 Mar 26.

PMID:
29779773
10.

Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study.

Zignol M, Cabibbe AM, Dean AS, Glaziou P, Alikhanova N, Ama C, Andres S, Barbova A, Borbe-Reyes A, Chin DP, Cirillo DM, Colvin C, Dadu A, Dreyer A, Driesen M, Gilpin C, Hasan R, Hasan Z, Hoffner S, Hussain A, Ismail N, Kamal SMM, Khanzada FM, Kimerling M, Kohl TA, Mansjö M, Miotto P, Mukadi YD, Mvusi L, Niemann S, Omar SV, Rigouts L, Schito M, Sela I, Seyfaddinova M, Skenders G, Skrahina A, Tahseen S, Wells WA, Zhurilo A, Weyer K, Floyd K, Raviglione MC.

Lancet Infect Dis. 2018 Jun;18(6):675-683. doi: 10.1016/S1473-3099(18)30073-2. Epub 2018 Mar 21. Erratum in: Lancet Infect Dis. 2018 Mar 27;:.

11.

Systematic case finding for tuberculosis in HIV-infected people who inject drugs: experience from Pakistan.

Tahseen S, Shahnawaz H, Riaz U, Khanzada FM, Hussain A, Aslam W, von Euler-Chelpin M.

Int J Tuberc Lung Dis. 2018 Feb 1;22(2):187-193. doi: 10.5588/ijtld.17.0390.

PMID:
29506615
12.

Role of sacral neuromodulation in modern urogynaecology practice: a review of recent literature.

Tahseen S.

Int Urogynecol J. 2018 Aug;29(8):1081-1091. doi: 10.1007/s00192-017-3546-6. Epub 2018 Jan 4. Review.

PMID:
29302716
13.

Gastric specimens for diagnosing tuberculosis in adults unable to expectorate in Rawalpindi, Pakistan.

Aslam W, Tahseen S, Schomotzer C, Hussain A, Khanzada F, Ul Haq M, Mahmood N, Fatima R, Qadeer E, Heldal E.

Public Health Action. 2017 Jun 21;7(2):141-146. doi: 10.5588/pha.16.0126.

14.

Evaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatment.

Driesen M, Kondo Y, de Jong BC, Torrea G, Asnong S, Desmaretz C, Mostofa KSM, Tahseen S, Whitfield MG, Cirillo DM, Miotto P, Cabibbe AM, Rigouts L.

Clin Microbiol Infect. 2018 Jan;24(1):60-64. doi: 10.1016/j.cmi.2017.05.026. Epub 2017 Jun 3.

15.

Fluoroquinolone consumption and -resistance trends in Mycobacterium tuberculosis and other respiratory pathogens: Ecological antibiotic pressure and consequences in Pakistan, 2009-2015.

Shakoor S, Tahseen S, Jabeen K, Fatima R, Malik FR, Rizvi AH, Hasan R.

Int J Mycobacteriol. 2016 Dec;5(4):412-416. doi: 10.1016/j.ijmyco.2016.07.008. Epub 2016 Aug 17.

16.

Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project.

Zignol M, Dean AS, Alikhanova N, Andres S, Cabibbe AM, Cirillo DM, Dadu A, Dreyer A, Driesen M, Gilpin C, Hasan R, Hasan Z, Hoffner S, Husain A, Hussain A, Ismail N, Kamal M, Mansjö M, Mvusi L, Niemann S, Omar SV, Qadeer E, Rigouts L, Ruesch-Gerdes S, Schito M, Seyfaddinova M, Skrahina A, Tahseen S, Wells WA, Mukadi YD, Kimerling M, Floyd K, Weyer K, Raviglione MC.

Lancet Infect Dis. 2016 Oct;16(10):1185-1192. doi: 10.1016/S1473-3099(16)30190-6. Epub 2016 Jul 7.

17.

Read the new microscopy handbook: even the Ziehl-Neelsen technique has changed.

Angra P, Ridderhof J, Tahseen S, Van Deun A.

Int J Tuberc Lung Dis. 2016 Apr;20(4):567. doi: 10.5588/ijtld.16.0009. No abstract available.

18.

Use of Xpert(®) MTB/RIF assay in the first national anti-tuberculosis drug resistance survey in Pakistan.

Tahseen S, Qadeer E, Khanzada FM, Rizvi AH, Dean A, Van Deun A, Zignol M.

Int J Tuberc Lung Dis. 2016 Apr;20(4):448-55. doi: 10.5588/ijtld.15.0645.

PMID:
26970152
19.

Population Based National Tuberculosis Prevalence Survey among Adults (>15 Years) in Pakistan, 2010-2011.

Qadeer E, Fatima R, Yaqoob A, Tahseen S, Ul Haq M, Ghafoor A, Asif M, Straetemans M, Tiemersma EW.

PLoS One. 2016 Feb 10;11(2):e0148293. doi: 10.1371/journal.pone.0148293. eCollection 2016.

20.

Correlation of Self-Reported Questionnaire (KOOS) with Some Objective Measures in Primary OA Knee Patients.

Sivachidambaram K, Ateef M, Tahseen S.

ISRN Rheumatol. 2014 Jan 16;2014:301485. doi: 10.1155/2014/301485. eCollection 2014.

21.

Evaluation of diagnostic potential of Rv3803c and Rv2626c recombinant antigens in TB endemic country Pakistan.

Ashraf S, Saqib MA, Sharif MZ, Khatak AA, Khan SN, Malik SA, Tahseen S, Khanum A.

J Immunoassay Immunochem. 2014;35(2):120-9. doi: 10.1080/15321819.2013.824897.

PMID:
24295176
22.

Xpert(®) MTB/RIF under routine conditions in diagnosing pulmonary tuberculosis: a study in two hospitals in Pakistan.

Shah SK, Kumar AM, Dogar OF, Khan MA, Qadeer E, Tahseen S, Masood F, Chandio AK, Edginton ME.

Public Health Action. 2013 Mar 21;3(1):20-2. doi: 10.5588/pha.12.0081.

23.

Plasma antibody profiles as diagnostic biomarkers for tuberculosis.

Khan IH, Ravindran R, Krishnan VV, Awan IN, Rizvi SK, Saqib MA, Shahzad MI, Tahseen S, Ireton G, Goulding CW, Felgner P, DeRiemer K, Khanum A, Luciw PA.

Clin Vaccine Immunol. 2011 Dec;18(12):2148-53. doi: 10.1128/CVI.05304-11. Epub 2011 Oct 5.

24.

Delay in diagnosis of tuberculosis in Rawalpindi, Pakistan.

Saqib MA, Awan IN, Rizvi SK, Shahzad MI, Mirza ZS, Tahseen S, Khan IH, Khanum A.

BMC Res Notes. 2011 May 26;4:165. doi: 10.1186/1756-0500-4-165.

26.

Effect of transobturator tape on overactive bladder symptoms and urge urinary incontinence in women with mixed urinary incontinence.

Tahseen S, Reid P.

Obstet Gynecol. 2009 Mar;113(3):617-23. doi: 10.1097/AOG.0b013e31819639e3.

PMID:
19300325
27.

Judging respiratory specimen acceptability for AFB microscopy: visual vs. microscopic screening.

Khan MS, Dar O, Tahseen S, Godfrey-Faussett P.

Trop Med Int Health. 2009 May;14(5):571-5. doi: 10.1111/j.1365-3156.2009.02260.x. Epub 2009 Mar 2.

28.

Psychological distress associated with colposcopy: patients' perception.

Tahseen S, Reid PC.

Eur J Obstet Gynecol Reprod Biol. 2008 Jul;139(1):90-4. Epub 2007 Nov 5.

PMID:
17980478
29.

Short-term complications of the trans-obturator foramen procedure for urinary stress incontinence.

Tahseen S, Reid PC, Charan P.

J Obstet Gynaecol. 2007 Jul;27(5):500-2.

PMID:
17701800
30.

An unusual case involving a tear in the uterosacral ligament following a prolonged second stage of labour.

Rauf A, Tahseen S, Jenkinson SD.

J Obstet Gynaecol. 2005 Nov;25(8):813-4. No abstract available.

PMID:
16368595
31.

A case of pseudomyxoma peritonei with a unique palliative therapy.

Tahseen S, McLean G.

J Obstet Gynaecol. 2003 Nov;23(6):679-80. No abstract available.

PMID:
14617486
32.

Spontaneous delivery through perineum, bypassing the vaginal introitus.

Tahseen S, McLean G.

J Obstet Gynaecol. 2003 Nov;23(6):671-2. No abstract available.

PMID:
14617481
34.

Vaginal route as the norm when planning hysterectomy for benign conditions: change in practice.

Varma R, Tahseen S, Lokugamage AU, Kunde D.

Obstet Gynecol. 2001 Apr;97(4):613-6.

PMID:
11275037
35.

Chromium-tolerant bacteria isolated from industrial effluents and their use in detoxication of hexavalent chromium.

Shakoori AR, Tahseen S, Haq RU.

Folia Microbiol (Praha). 1999;44(1):50-4.

PMID:
10489694

Supplemental Content

Loading ...
Support Center